Navigation Links
Sinovac Reports Unaudited Second Quarter Financial Results
Date:8/14/2014

n>(0.01)

(0.04) SINOVAC BIOTECH LTD.Consolidated Statements of Cash FlowsFor the three and six months ended June 30, 2013 and 2014(Unaudited)(Expressed in thousands of U.S. Dollars)Three months endedSix months ended June 30June 302013201420132014Cash flows provided by (used in) operating activitiesNet income (loss)

$

1,914

$

(3,022)$

(452)

$

(2,581)  Adjustments to reconcile net income (loss) to net cash  provided by (used in) operating activities: - deferred income taxes(17)58(15)369 - stock-based compensation6271138143 - inventory provision768321768542 - provision for doubtful accounts604132886294 - impairment of equipment and loss on disposal-29(3)29- depreciation of property, plant and equipment and amo
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results
2. Sinovac to Participate in UBS Asia Healthcare CEO Summit in November 2013
3. Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility
4. Sinovac to Present at 55th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
5. Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
6. Pressure BioSciences, Inc. Reports Second Quarter 2014 Financial Results and Provides Business Update
7. RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2014
8. Synthetic Biologics Reports Second Quarter 2014 Financial Results and Operational Highlights
9. MarketResearch.com: New Biotechnology Market Research Reports Added to Kalorama Information Knowledge Center
10. GenVec Reports Second Quarter 2014 Financial Results
11. BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... LAWRENCEVILLE, N.J. , May 28, 2015 ... announced that it has received commitments from two institutional ... million of the Company,s common stock in an at-the-market ... warrants to purchase common stock. The Company ... pursuant to which the Company agreed to sell an ...
(Date:5/28/2015)... , May 28, 2015 RXi Pharmaceuticals ... on discovering and developing innovative therapeutics, primarily in the ... of a public offering of 26 million units at ... for gross proceeds of approximately $10.4 million. Each unit ... a 13-month overallotment purchase right to purchase 0.50 of ...
(Date:5/28/2015)... Glenn Keet, CEO of Clinovo ... EMR/EHR Clinical Data Integration with EDC Systems ” at ... DC on June 14th-18th. , During the presentation, Glenn ... with EDC, and will examine the value of patient ... electronic health records/electronic medical records integration. , The ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 In two ... James L. Sherley, M.D., Ph.D., will present the company’s ... In a conference talk, he will describe ... culture designs with computer simulation to produce the first-ever ... number and quality over time in culture. When ...
Breaking Biology Technology:Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 3RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 3Clinovo Presents at the DIA 2015 51st Annual Meeting in Washington, DC on June 14th-18th 2Asymmetrex Will Discuss the Importance of Adult Tissue Stem Cell Time with 3D Tissue Engineers at the 14th Annual World Preclinical Congress in Boston in June 2Asymmetrex Will Discuss the Importance of Adult Tissue Stem Cell Time with 3D Tissue Engineers at the 14th Annual World Preclinical Congress in Boston in June 3
... Acquisition enhances Elsevier,s ability to help ... and content management efficiency Elsevier ... medical information products and services, announced today the ... and workflow productivity solutions provider for researchers and ...
... PharmaVentures announced today that it was delighted ... deal which won Scrip,s ,Outsourcing Deal of the Year 2011,. ... it was "one the largest and most comprehensive R&D alliances ... terms of the agreement, Sanofi retains access to some of ...
... January 11, 2012 Oxford BioTherapeutics (OBT) today ... senior clinical advisor and non-executive director.  Dr Begley, who was ... Research at Amgen, will take on a key role in ... it advances its pipeline of oncology antibody-based drugs into clinical ...
Cached Biology Technology:Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions 2Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions 3PharmaVentures' Client Sanofi Wins Scrip 'Outsourcing Deal of the Year Award' 2Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director 2Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director 3
(Date:5/21/2015)... The Sync Project™ , a global collaboration harnessing ... a collaborative partnership with Berklee,s Institute for Creative ... on original research, joint course development and an internship ... Sync Project and BerkleeICE are exploring the launch of ... academic year.  The course will focus ...
(Date:5/19/2015)... DUBLIN , May 19, 2015 /PRNewswire/ ... ) has announced the addition of the  ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A ... provides an in-depth analysis of the current ... introduction of gene-based tests, their working principles ...
(Date:5/11/2015)... 11, 2015  Through a well-rounded UAS delegation representing private ... a strong showing at AUVSI,s Unmanned 2015 conference last week ... Ohio,s UAS industry met with over 200 ... points along the UAS ecosystem. "Our message ... President for Aerospace Rich Knoll . "If you want ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3Global Genetic Testing Market Outlook 2018 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... door" on bacteria that would otherwise infect the plant,s leaves ... of researchers in Denmark, at the University of California, Davis, ... will appear June 29 in the online journal Public ... plants, immune systems and will likely find application in better ...
... get a new arsenal for meningitis treatment and the ... peptide nanoparticles developed by scientists at the Institute of ... Nature Nanotechnology . The stable bioengineered nanoparticles ... and fungal cells that could cause fatal infections and ...
... are in awe of what their football heroes can do ... strangely mysterious. Although being in excellent physical condition undoubtedly helps, ... turn an average bloke into a Ronaldo. Now, scientists from ... "something else" might be. Dr. Robbie Wilson will talk about ...
Cached Biology News:Plant protein 'doorkeepers' block invading microbes, study finds 2Plant protein 'doorkeepers' block invading microbes, study finds 3Singapore nanotechnology combats fatal brain infections 2What makes a great footballer? 2
Verotoxin IIbeta (457)...
Thermo Labsystems offers a basic reader for 96-well microplates that is especially adapted for ELISA and other colorimetric assays....
... Universal Vacuum System UVS400 is a multi-tasking ... UVS400 combines a refrigerated vapor trap and ... single integrated unit. The easy-to-use, wide-mouth glass ... into single jar for easy disposal. The ...
This antibody detects ubiquitinated proteins on SDS-PAGE immunoblots. It does not detect free ubiquitin....
Biology Products: